Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruva...
Q2 2026
Jul 30, 2026
Q1 2026
Apr 29, 2026
FY 2025
Feb 12, 2026
Q4 2025
Q3 2025
Oct 30, 2025